📊 This is a profile preview from the Tablestat.com Platform Request a Free Trial Now

Life Sciences Genetic Testing Platforms sector

Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Life Sciences Genetic Testing Platforms

1.1 - About Life Sciences Genetic Testing Platforms sector

Companies in this category build software platforms that power genetic testing across clinical and research settings. Life Sciences Genetic Testing Platforms unify sample intake, sequencing data processing, and clinical reporting to streamline end‑to‑end workflows. Strategic buyers in this space deliver accuracy, scalability, and compliance while integrating with EHRs and payers, enabling laboratories to expand test menus in oncology, rare disease, reproductive health, and pharmacogenomics with faster turnaround and lower cost.

Typical offerings include cloud or on‑premise NGS pipelines that automate alignment, variant calling, CNV detection and quality control. Vendors pair configurable genomics LIMS for sample, reagent and workflow management with knowledgebases and interpretation tools aligned to ACMG/AMP guidelines, generating templated clinical reports. They add patient and provider ordering portals and integrations to EHR, LIS and billing systems, while delivering audit trails, hardened security, instrument connectivity via APIs, and multi‑lab scalability.

These vendors primarily serve clinical diagnostics laboratories, hospital and reference lab networks, and biopharma research groups running translational genomics. Customers typically achieve higher throughput, reduced turnaround time, improved diagnostic yield, and stronger compliance under CLIA, CAP, HIPAA, and GDPR. Platforms also improve cost‑per‑sample economics, enable rapid assay launches, and support expansion into oncology, pharmacogenomics, carrier screening, and prenatal testing across distributed lab sites.

2. Buyers in the Life Sciences Genetic Testing Platforms sector

2.1 Top strategic acquirers of Life Sciences Genetic Testing Platforms companies

Natera Logo

Natera

HQ: United States Website
  • Description: Provider of genetic testing solutions and end-to-end support services for women’s health, oncology and other specialties, leveraging cell-free DNA and next-generation sequencing. Its NateraCore program offers education, financial access, streamlined ordering, electronic results, and genetic counseling to help clinicians integrate hereditary cancer and other screenings into routine care.
  • Key Products:
  • NateraCore Services: Comprehensive program delivering patient education, financial access tools, digital and paper ordering, electronic results, and genetic counselor sessions to simplify genetic testing implementation
  • Empower Hereditary Cancer Test: Curated gene panels integrated with mammography software, reporting genetic findings with Tyrer-Cuzick score for a complete breast cancer risk view
  • NateraConnect Portal: Web platform allowing paper or digital order entry, integration with EHR networks, and electronic results management within clinicians’ systems
  • NEVA – Natera Educational Virtual Assistant: Digital screening and interactive results tool that flags increased-risk patients, delivers reports, and guides patients through testing and results understanding.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Life Sciences Genetic Testing Platforms sector

M&A buyer group 1: LIMS

4 companies View group →
Description: Companies in the Enterprise Life Sciences LIMS Platforms category build software that orchestrates end‑to‑end laboratory operations for research, development, and regulated testing. Their systems centralize sample data, standardize workflows, and provide auditable traceability from accessioning through results reporting. By connecting instruments, people, and processes, these vendors help life sciences organizations improve data integrity, compliance, and throughput while reducing cycle times across multi‑site labs.
Elemental Machines

Elemental Machines

Website • HQ: United States
  • Type: N/A
  • Employees: ●●●●●
  • Description: Provider of an intelligent operations platform that integrates IoT sensors, custom hardware and software to give labs, biopharma and manufacturing sites real-time monitoring, predictive analytics and actionable insights, transforming equipment oversight, compliance and operational efficiency from reactive to proactive.
  • Key Products:
  • Intelligent Operations Platform: IoT-connected hardware, sensors and software collect high-sample-rate data, unify physical-digital worlds and provide actionable insights that simplify, optimize and augment laboratory and manufacturing operations
  • AI-Driven Predictive Analytics: Contextual anomaly detection, custom AI models and proactive maintenance insights forecast issues, reduce downtime and extend equipment lifespan while displaying real-time data in user-friendly dashboards
  • Freezer Monitoring Solutions: Continuous cold-storage monitoring with alerts ensures freezer health, protects samples during off-hours and safeguards compliance for life-science laboratories
  • Custom Dashboards: Highly configurable dashboards let users combine multiple data sources, monitor key metrics in real-time, tailor insights to workflows and simplify data-driven decision-making across environmental and utilization parameters.
🔒
🔒
🔒
🔒
🔒
🔒
🔒 View all 4 companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms in Life Sciences Genetic Testing Platforms sector

3.1 - Buyout funds in the Life Sciences Genetic Testing Platforms sector

Buyout Funds investing in Life Sciences Genetic Testing Platforms companies

51+ funds
Description: Buyout funds focused on Life Sciences Genetic Testing Platforms companies globally.

EQT

Website • HQ: Sweden
  • Type: Buyout
  • Fund Size: $●●●m
  • Investment Range: $●●-●●●m
  • Focus: Technology companies in Life Sciences Genetic Testing Platforms
  • Relevant M&A transactions / similar portfolio companies:
🔒
🔒
🔒
🔒
🔒
🔒

2.2 - Strategic buyer groups for Life Sciences Genetic Testing Platforms sector

Growth Equity Funds in Life Sciences Genetic Testing Platforms companies

41+ funds
Description: Growth equity funds focused on Life Sciences Genetic Testing Platforms companies globally.

Idinvest Partners

Website • HQ: France
  • Type: Growth
  • Fund Size: $●●●m
  • Investment Range: $●●-●●●m
  • Focus: High-growth companies in Life Sciences Genetic Testing Platforms
  • Relevant investments / similar portfolio companies:
🔒
🔒
🔒
🔒
🔒
🔒
🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Life Sciences Genetic Testing Platforms companies

4.2 - Public trading comparable groups for Life Sciences Genetic Testing Platforms sector

Description: Companies in this public trading comparables group develop and commercialize genomics tools and precision oncology diagnostics. Business models span CLIA/FDA-approved liquid biopsy assays, comprehensive genomic profiling, synthetic DNA manufacturing, and outsourced sequencing and biobanking services. They are comparable as valuation benchmarks given shared exposure to NGS workflows, recurring consumables and services revenue, payer/provider adoption cycles, and biopharma research demand.
  • Enterprise value: $●●●m
  • Market Cap: $●●●m
  • EV/Revenue: ●.●x
  • EV/EBITDA: ●●.●x
  • Description: Provider of a range of trucks, commercial cars and vans, sport utility vehicles, and luxury vehicles worldwide; offers retail installment sale contracts and direct financing leases for new vehicles; sells vehicles, service parts, and accessories through distributors and dealers; provides wholesale loans to dealers for vehicle inventory purchase and dealership operations.
  • Key Products:
  • Trucks: Range of Ford trucks with varied functionalities for different use cases
  • Commercial Vehicles: Vans and commercial cars suitable for business applications
  • Luxury Vehicles: Premium Lincoln-branded vehicles with advanced features and luxury
  • Retail Financing: Retail installment sale contracts and direct financing leases for vehicle purchases
  • Fleet Solutions: Wholesale loans to dealers for vehicle inventory and dealership operations.
🔒
🔒
🔒
🔒
🔒
🔒
🔒 View all 5 companies in this group
Request Free Trial Now →
🔒
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions in the Life Sciences Genetic Testing Platforms sector

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

Buyers & Acquirers in Life Sciences Genetic Testing Platforms sector

Who are the top strategic acquirers of Life Sciences Genetic Testing Platforms companies?

Top strategic buyers in this sector include Natera, a provider of genetic testing solutions and end-to-end support services for women’s health, oncology and other specialties, leveraging cell-free dna and next-generation sequencing. its nateracore program offers education, financial access, streamlined ordering, electronic results, and genetic counseling to help clinicians integrate hereditary cancer and other screenings into routine care. .

Which buyer groups are most relevant for Life Sciences Genetic Testing Platforms companies?

Relevant strategic buyer groups similar to the Life Sciences Genetic Testing Platforms sector include LIMS because they share similar customer segments and product capabilities.

Financial Investors in Life Sciences Genetic Testing Platforms sector

Which are the top PE firms investing in Life Sciences Genetic Testing Platforms companies?

Potential investors in the broader Life Sciences Genetic Testing Platforms space include Idinvest Partners and EQT.

Who are the top buyout funds acquiring Life Sciences Genetic Testing Platforms companies?

Active PE funds and buyout funds acquiring companies in the Life Sciences Genetic Testing Platforms space include EQT.

Who are the top growth equity funds investing in Life Sciences Genetic Testing Platforms companies?

Growth funds investing in the broader Life Sciences Genetic Testing Platforms sector include Idinvest Partners.

Valuation of Companies in Life Sciences Genetic Testing Platforms sector

Which are the key public companies that are relevant trading comps for Life Sciences Genetic Testing Platforms companies?

Key trading comparable groups include Ford, a provider of a range of trucks, commercial cars and vans, sport utility vehicles, and luxury vehicles worldwide; offers retail installment sale contracts and direct financing leases for new vehicles; sells vehicles, service parts, and accessories through distributors and dealers; provides wholesale loans to dealers for vehicle inventory purchase and dealership operations..

Which are the key trading comparable groups for Life Sciences Genetic Testing Platforms companies?

Similar trading comparable companies include Genomics Tools and Precision Diagnostics Companies. Our platform tracks detailed trading comparable groups in the Life Sciences Genetic Testing Platforms sector with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in the Life Sciences Genetic Testing Platforms sector?

Our platform tracks M&A transactions in the Life Sciences Genetic Testing Platforms sector with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Life Sciences Genetic Testing Platforms?

Access recent funding rounds in the Life Sciences Genetic Testing Platforms sector including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors, valuations, and use of proceeds.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Life Sciences Genetic Testing Platforms

Launch login modal Launch register modal